nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—peripheral nervous system neoplasm	0.383	1	CbGaD
Bepridil—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0262	0.226	CbGbCtD
Bepridil—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0262	0.226	CbGbCtD
Bepridil—KCNQ1—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0226	0.167	CbGeAlD
Bepridil—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0182	0.157	CbGbCtD
Bepridil—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0156	0.116	CbGeAlD
Bepridil—KCNQ1—cochlea—peripheral nervous system neoplasm	0.0114	0.0844	CbGeAlD
Bepridil—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0112	0.0964	CbGbCtD
Bepridil—KCNQ1—internal ear—peripheral nervous system neoplasm	0.0108	0.08	CbGeAlD
Bepridil—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0104	0.0899	CbGbCtD
Bepridil—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0103	0.0883	CbGbCtD
Bepridil—CACNA1D—cochlea—peripheral nervous system neoplasm	0.00792	0.0585	CbGeAlD
Bepridil—CACNA1D—internal ear—peripheral nervous system neoplasm	0.0075	0.0555	CbGeAlD
Bepridil—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00699	0.0603	CbGbCtD
Bepridil—CACNA1A—nerve—peripheral nervous system neoplasm	0.00676	0.0499	CbGeAlD
Bepridil—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00659	0.0568	CbGbCtD
Bepridil—CALM1—trigeminal nerve—peripheral nervous system neoplasm	0.00527	0.0389	CbGeAlD
Bepridil—CALM1—cranial nerve—peripheral nervous system neoplasm	0.00375	0.0277	CbGeAlD
Bepridil—CALM2—pons—peripheral nervous system neoplasm	0.00373	0.0275	CbGeAlD
Bepridil—CALM1—pons—peripheral nervous system neoplasm	0.00371	0.0274	CbGeAlD
Bepridil—CACNA1A—brainstem—peripheral nervous system neoplasm	0.0029	0.0214	CbGeAlD
Bepridil—TNNC1—trigeminal ganglion—peripheral nervous system neoplasm	0.00274	0.0203	CbGeAlD
Bepridil—PDE1A—brainstem—peripheral nervous system neoplasm	0.00212	0.0157	CbGeAlD
Bepridil—CALM2—nerve—peripheral nervous system neoplasm	0.00193	0.0143	CbGeAlD
Bepridil—CALM1—nerve—peripheral nervous system neoplasm	0.00192	0.0142	CbGeAlD
Bepridil—CALM2—ganglion—peripheral nervous system neoplasm	0.00191	0.0141	CbGeAlD
Bepridil—CALM1—ganglion—peripheral nervous system neoplasm	0.0019	0.014	CbGeAlD
Bepridil—CACNA1A—cerebellum—peripheral nervous system neoplasm	0.00143	0.0106	CbGeAlD
Bepridil—Trimethaphan—BCHE—peripheral nervous system neoplasm	0.00127	0.846	CrCbGaD
Bepridil—PDE1B—cerebellum—peripheral nervous system neoplasm	0.00125	0.00922	CbGeAlD
Bepridil—CALM3—trigeminal ganglion—peripheral nervous system neoplasm	0.00119	0.00882	CbGeAlD
Bepridil—CALM3—parotid gland—peripheral nervous system neoplasm	0.00113	0.00832	CbGeAlD
Bepridil—ATP1A1—trigeminal ganglion—peripheral nervous system neoplasm	0.00106	0.00787	CbGeAlD
Bepridil—PDE1A—cerebellum—peripheral nervous system neoplasm	0.00105	0.00773	CbGeAlD
Bepridil—CACNA2D2—cerebellum—peripheral nervous system neoplasm	0.00101	0.00744	CbGeAlD
Bepridil—ATP1A1—parotid gland—peripheral nervous system neoplasm	0.001	0.00742	CbGeAlD
Bepridil—ATP1A1—brainstem—peripheral nervous system neoplasm	0.000942	0.00696	CbGeAlD
Bepridil—CALM2—trigeminal ganglion—peripheral nervous system neoplasm	0.000938	0.00693	CbGeAlD
Bepridil—CALM1—trigeminal ganglion—peripheral nervous system neoplasm	0.000933	0.0069	CbGeAlD
Bepridil—CALM2—parotid gland—peripheral nervous system neoplasm	0.000884	0.00654	CbGeAlD
Bepridil—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000849	0.00628	CbGeAlD
Bepridil—CALM2—brainstem—peripheral nervous system neoplasm	0.00083	0.00613	CbGeAlD
Bepridil—CALM1—brainstem—peripheral nervous system neoplasm	0.000826	0.0061	CbGeAlD
Bepridil—CACNA1H—cerebellum—peripheral nervous system neoplasm	0.000816	0.00603	CbGeAlD
Bepridil—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.000674	0.00498	CbGeAlD
Bepridil—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.000622	0.0046	CbGeAlD
Bepridil—CALM3—cerebellum—peripheral nervous system neoplasm	0.000521	0.00385	CbGeAlD
Bepridil—ATP1A1—cerebellum—peripheral nervous system neoplasm	0.000465	0.00343	CbGeAlD
Bepridil—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000458	0.00339	CbGeAlD
Bepridil—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000452	0.00225	CcSEcCtD
Bepridil—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00222	CcSEcCtD
Bepridil—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000442	0.0022	CcSEcCtD
Bepridil—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00044	0.00219	CcSEcCtD
Bepridil—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00218	CcSEcCtD
Bepridil—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00218	CcSEcCtD
Bepridil—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000438	0.00218	CcSEcCtD
Bepridil—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.00218	CcSEcCtD
Bepridil—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000435	0.00216	CcSEcCtD
Bepridil—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000434	0.00216	CcSEcCtD
Bepridil—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000431	0.00214	CcSEcCtD
Bepridil—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00043	0.00214	CcSEcCtD
Bepridil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000427	0.00212	CcSEcCtD
Bepridil—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000427	0.00212	CcSEcCtD
Bepridil—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.00211	CcSEcCtD
Bepridil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000424	0.00211	CcSEcCtD
Bepridil—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000424	0.00211	CcSEcCtD
Bepridil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000424	0.00211	CcSEcCtD
Bepridil—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000424	0.00211	CcSEcCtD
Bepridil—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.0021	CcSEcCtD
Bepridil—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000418	0.00208	CcSEcCtD
Bepridil—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000418	0.00208	CcSEcCtD
Bepridil—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.00206	CcSEcCtD
Bepridil—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000414	0.00206	CcSEcCtD
Bepridil—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000414	0.00206	CcSEcCtD
Bepridil—CALM2—cerebellum—peripheral nervous system neoplasm	0.000409	0.00302	CbGeAlD
Bepridil—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000408	0.00203	CcSEcCtD
Bepridil—CALM1—cerebellum—peripheral nervous system neoplasm	0.000407	0.00301	CbGeAlD
Bepridil—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.00202	CcSEcCtD
Bepridil—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.0004	0.00199	CcSEcCtD
Bepridil—Shock—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.00199	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000399	0.00199	CcSEcCtD
Bepridil—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000397	0.00198	CcSEcCtD
Bepridil—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000393	0.00195	CcSEcCtD
Bepridil—Oedema—Vincristine—peripheral nervous system neoplasm	0.000391	0.00195	CcSEcCtD
Bepridil—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000388	0.00193	CcSEcCtD
Bepridil—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.00193	CcSEcCtD
Bepridil—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00191	CcSEcCtD
Bepridil—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00191	CcSEcCtD
Bepridil—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00191	CcSEcCtD
Bepridil—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000381	0.00189	CcSEcCtD
Bepridil—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00038	0.00189	CcSEcCtD
Bepridil—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000378	0.00188	CcSEcCtD
Bepridil—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00186	CcSEcCtD
Bepridil—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000373	0.00186	CcSEcCtD
Bepridil—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000373	0.00275	CbGeAlD
Bepridil—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000371	0.00274	CbGeAlD
Bepridil—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000371	0.00184	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00184	CcSEcCtD
Bepridil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00037	0.00184	CcSEcCtD
Bepridil—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.00183	CcSEcCtD
Bepridil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000367	0.00182	CcSEcCtD
Bepridil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000367	0.00182	CcSEcCtD
Bepridil—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00181	CcSEcCtD
Bepridil—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.0018	CcSEcCtD
Bepridil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000362	0.0018	CcSEcCtD
Bepridil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.0018	CcSEcCtD
Bepridil—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000361	0.0018	CcSEcCtD
Bepridil—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00036	0.00179	CcSEcCtD
Bepridil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00178	CcSEcCtD
Bepridil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000358	0.00178	CcSEcCtD
Bepridil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000357	0.00178	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000357	0.00177	CcSEcCtD
Bepridil—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.00177	CcSEcCtD
Bepridil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000354	0.00176	CcSEcCtD
Bepridil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000354	0.00176	CcSEcCtD
Bepridil—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000354	0.00176	CcSEcCtD
Bepridil—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.00176	CcSEcCtD
Bepridil—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000351	0.00175	CcSEcCtD
Bepridil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00174	CcSEcCtD
Bepridil—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000349	0.00174	CcSEcCtD
Bepridil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00173	CcSEcCtD
Bepridil—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000347	0.00173	CcSEcCtD
Bepridil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000346	0.00172	CcSEcCtD
Bepridil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000346	0.00172	CcSEcCtD
Bepridil—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000346	0.00172	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00171	CcSEcCtD
Bepridil—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000341	0.0017	CcSEcCtD
Bepridil—Rash—Topotecan—peripheral nervous system neoplasm	0.000341	0.00169	CcSEcCtD
Bepridil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00034	0.00169	CcSEcCtD
Bepridil—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00034	0.00169	CcSEcCtD
Bepridil—Cough—Etoposide—peripheral nervous system neoplasm	0.000339	0.00169	CcSEcCtD
Bepridil—Headache—Topotecan—peripheral nervous system neoplasm	0.000338	0.00168	CcSEcCtD
Bepridil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00168	CcSEcCtD
Bepridil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00168	CcSEcCtD
Bepridil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000338	0.00168	CcSEcCtD
Bepridil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000338	0.00168	CcSEcCtD
Bepridil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.00168	CcSEcCtD
Bepridil—Headache—Tretinoin—peripheral nervous system neoplasm	0.000336	0.00167	CcSEcCtD
Bepridil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000336	0.00167	CcSEcCtD
Bepridil—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000335	0.00167	CcSEcCtD
Bepridil—Pain—Vincristine—peripheral nervous system neoplasm	0.000335	0.00166	CcSEcCtD
Bepridil—Constipation—Vincristine—peripheral nervous system neoplasm	0.000335	0.00166	CcSEcCtD
Bepridil—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000335	0.00166	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000334	0.00166	CcSEcCtD
Bepridil—Rash—Melphalan—peripheral nervous system neoplasm	0.000334	0.00166	CcSEcCtD
Bepridil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000333	0.00166	CcSEcCtD
Bepridil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00165	CcSEcCtD
Bepridil—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00164	CcSEcCtD
Bepridil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.0016	CcSEcCtD
Bepridil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.0016	CcSEcCtD
Bepridil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000321	0.0016	CcSEcCtD
Bepridil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00032	0.00159	CcSEcCtD
Bepridil—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00159	CcSEcCtD
Bepridil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000318	0.00158	CcSEcCtD
Bepridil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000318	0.00158	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000315	0.00157	CcSEcCtD
Bepridil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000314	0.00156	CcSEcCtD
Bepridil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000314	0.00156	CcSEcCtD
Bepridil—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000313	0.00155	CcSEcCtD
Bepridil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000311	0.00155	CcSEcCtD
Bepridil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000309	0.00154	CcSEcCtD
Bepridil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000309	0.00154	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.00154	CcSEcCtD
Bepridil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000309	0.00153	CcSEcCtD
Bepridil—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000307	0.00152	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00151	CcSEcCtD
Bepridil—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000302	0.0015	CcSEcCtD
Bepridil—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000301	0.0015	CcSEcCtD
Bepridil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0003	0.00149	CcSEcCtD
Bepridil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00149	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.00147	CcSEcCtD
Bepridil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000296	0.00147	CcSEcCtD
Bepridil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00145	CcSEcCtD
Bepridil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.00144	CcSEcCtD
Bepridil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000285	0.00142	CcSEcCtD
Bepridil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000283	0.00141	CcSEcCtD
Bepridil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000282	0.0014	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.0014	CcSEcCtD
Bepridil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000281	0.0014	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00139	CcSEcCtD
Bepridil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.00138	CcSEcCtD
Bepridil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000276	0.00137	CcSEcCtD
Bepridil—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000276	0.00137	CcSEcCtD
Bepridil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000274	0.00136	CcSEcCtD
Bepridil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000274	0.00136	CcSEcCtD
Bepridil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000271	0.00135	CcSEcCtD
Bepridil—Pain—Etoposide—peripheral nervous system neoplasm	0.000271	0.00135	CcSEcCtD
Bepridil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.00134	CcSEcCtD
Bepridil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000268	0.00133	CcSEcCtD
Bepridil—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000267	0.00133	CcSEcCtD
Bepridil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00026	0.00129	CcSEcCtD
Bepridil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000259	0.00129	CcSEcCtD
Bepridil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000259	0.00129	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00128	CcSEcCtD
Bepridil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00127	CcSEcCtD
Bepridil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00127	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000255	0.00127	CcSEcCtD
Bepridil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.00127	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00125	CcSEcCtD
Bepridil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000251	0.00125	CcSEcCtD
Bepridil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000251	0.00125	CcSEcCtD
Bepridil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000248	0.00124	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000248	0.00123	CcSEcCtD
Bepridil—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.00123	CcSEcCtD
Bepridil—Rash—Vincristine—peripheral nervous system neoplasm	0.000247	0.00123	CcSEcCtD
Bepridil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000247	0.00123	CcSEcCtD
Bepridil—Headache—Vincristine—peripheral nervous system neoplasm	0.000245	0.00122	CcSEcCtD
Bepridil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.0012	CcSEcCtD
Bepridil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000237	0.00118	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.00117	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00116	CcSEcCtD
Bepridil—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.000233	0.155	CrCbGaD
Bepridil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000232	0.00116	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00115	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00115	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00114	CcSEcCtD
Bepridil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000227	0.00113	CcSEcCtD
Bepridil—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000226	0.00167	CbGeAlD
Bepridil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00111	CcSEcCtD
Bepridil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00109	CcSEcCtD
Bepridil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00108	CcSEcCtD
Bepridil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000217	0.00108	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00107	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00107	CcSEcCtD
Bepridil—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00107	CcSEcCtD
Bepridil—Tension—Epirubicin—peripheral nervous system neoplasm	0.000214	0.00106	CcSEcCtD
Bepridil—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000212	0.00105	CcSEcCtD
Bepridil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00021	0.00104	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00103	CcSEcCtD
Bepridil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000206	0.00102	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00102	CcSEcCtD
Bepridil—Rash—Etoposide—peripheral nervous system neoplasm	0.0002	0.000994	CcSEcCtD
Bepridil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.0002	0.000993	CcSEcCtD
Bepridil—Headache—Etoposide—peripheral nervous system neoplasm	0.000199	0.000988	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000988	CcSEcCtD
Bepridil—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000984	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000973	CcSEcCtD
Bepridil—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000973	CcSEcCtD
Bepridil—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000971	CcSEcCtD
Bepridil—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000957	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000952	CcSEcCtD
Bepridil—Cough—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000945	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000945	CcSEcCtD
Bepridil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000188	0.000937	CcSEcCtD
Bepridil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000935	CcSEcCtD
Bepridil—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000922	CcSEcCtD
Bepridil—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000919	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000902	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.0009	CcSEcCtD
Bepridil—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000899	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000886	CcSEcCtD
Bepridil—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000884	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000881	CcSEcCtD
Bepridil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000875	CcSEcCtD
Bepridil—Shock—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00087	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000865	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000855	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000853	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00085	CcSEcCtD
Bepridil—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000843	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000835	CcSEcCtD
Bepridil—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000818	CcSEcCtD
Bepridil—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000163	0.0012	CbGeAlD
Bepridil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000805	CcSEcCtD
Bepridil—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000805	CcSEcCtD
Bepridil—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.0008	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000794	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000791	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000788	CcSEcCtD
Bepridil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000786	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00078	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000778	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000768	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000763	CcSEcCtD
Bepridil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000756	CcSEcCtD
Bepridil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000756	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000745	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00074	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000735	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000729	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000727	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000723	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00072	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000711	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000706	CcSEcCtD
Bepridil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000699	CcSEcCtD
Bepridil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000699	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000699	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000699	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000669	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000647	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000647	CcSEcCtD
Bepridil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000634	CcSEcCtD
Bepridil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000605	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000587	CcSEcCtD
Bepridil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000585	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00056	CcSEcCtD
Bepridil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000557	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000557	CcSEcCtD
Bepridil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000554	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000541	CcSEcCtD
Bepridil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000525	CcSEcCtD
Bepridil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000516	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000515	CcSEcCtD
Bepridil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000512	CcSEcCtD
Bepridil—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000486	CcSEcCtD
Bepridil—CALM2—DAP12 interactions—AKT1—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM1—DAP12 interactions—AKT1—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM2—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM1—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ENO2—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ENO2—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—PDE1A—Immune System—NRAS—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.57e-05	0.000158	CbGpPWpGaD
Bepridil—CALM3—Disease—SLC2A1—peripheral nervous system neoplasm	2.56e-05	0.000157	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	2.56e-05	0.000157	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000157	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	2.55e-05	0.000157	CbGpPWpGaD
Bepridil—CALM2—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	2.53e-05	0.000155	CbGpPWpGaD
Bepridil—CALM1—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	2.53e-05	0.000155	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.53e-05	0.000155	CbGpPWpGaD
Bepridil—CALM1—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	2.52e-05	0.000155	CbGpPWpGaD
Bepridil—CALM2—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	2.52e-05	0.000155	CbGpPWpGaD
Bepridil—CALM3—Membrane Trafficking—AKT1—peripheral nervous system neoplasm	2.51e-05	0.000154	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.48e-05	0.000152	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.48e-05	0.000152	CbGpPWpGaD
Bepridil—CALM1—Disease—SLC2A1—peripheral nervous system neoplasm	2.48e-05	0.000152	CbGpPWpGaD
Bepridil—CALM2—Disease—SLC2A1—peripheral nervous system neoplasm	2.48e-05	0.000152	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	2.47e-05	0.000152	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	2.47e-05	0.000152	CbGpPWpGaD
Bepridil—CALM3—B Cell Activation—AKT1—peripheral nervous system neoplasm	2.46e-05	0.000151	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.44e-05	0.00015	CbGpPWpGaD
Bepridil—CALM2—Membrane Trafficking—AKT1—peripheral nervous system neoplasm	2.43e-05	0.000149	CbGpPWpGaD
Bepridil—CALM1—Membrane Trafficking—AKT1—peripheral nervous system neoplasm	2.43e-05	0.000149	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—MYC—peripheral nervous system neoplasm	2.41e-05	0.000148	CbGpPWpGaD
Bepridil—CALM2—B Cell Activation—AKT1—peripheral nervous system neoplasm	2.38e-05	0.000146	CbGpPWpGaD
Bepridil—CALM1—B Cell Activation—AKT1—peripheral nervous system neoplasm	2.38e-05	0.000146	CbGpPWpGaD
Bepridil—PDE1A—Disease—NRAS—peripheral nervous system neoplasm	2.37e-05	0.000146	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.36e-05	0.000145	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.36e-05	0.000145	CbGpPWpGaD
Bepridil—CALM3—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	2.36e-05	0.000145	CbGpPWpGaD
Bepridil—PDE1B—Immune System—NRAS—peripheral nervous system neoplasm	2.35e-05	0.000144	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—MYC—peripheral nervous system neoplasm	2.33e-05	0.000143	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—MYC—peripheral nervous system neoplasm	2.33e-05	0.000143	CbGpPWpGaD
Bepridil—CALM2—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	2.28e-05	0.00014	CbGpPWpGaD
Bepridil—CALM1—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	2.28e-05	0.00014	CbGpPWpGaD
Bepridil—CALM3—Metabolism—BCHE—peripheral nervous system neoplasm	2.25e-05	0.000138	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.25e-05	0.000138	CbGpPWpGaD
Bepridil—CALM3—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.23e-05	0.000137	CbGpPWpGaD
Bepridil—PDE1A—Disease—MYC—peripheral nervous system neoplasm	2.21e-05	0.000136	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—AKT1—peripheral nervous system neoplasm	2.21e-05	0.000136	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.18e-05	0.000134	CbGpPWpGaD
Bepridil—CALM3—RNF mutants show enhanced WNT signaling and proliferation—AKT1—peripheral nervous system neoplasm	2.18e-05	0.000134	CbGpPWpGaD
Bepridil—CALM2—Metabolism—BCHE—peripheral nervous system neoplasm	2.17e-05	0.000133	CbGpPWpGaD
Bepridil—CALM1—Metabolism—BCHE—peripheral nervous system neoplasm	2.17e-05	0.000133	CbGpPWpGaD
Bepridil—PDE1B—Disease—NRAS—peripheral nervous system neoplasm	2.17e-05	0.000133	CbGpPWpGaD
Bepridil—CALM1—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.15e-05	0.000132	CbGpPWpGaD
Bepridil—CALM2—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.15e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.14e-05	0.000132	CbGpPWpGaD
Bepridil—CALM3—Immune System—HGF—peripheral nervous system neoplasm	2.12e-05	0.00013	CbGpPWpGaD
Bepridil—CALM3—Metabolism—TH—peripheral nervous system neoplasm	2.11e-05	0.00013	CbGpPWpGaD
Bepridil—CALM2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—peripheral nervous system neoplasm	2.11e-05	0.00013	CbGpPWpGaD
Bepridil—CALM1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—peripheral nervous system neoplasm	2.11e-05	0.00013	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—ERBB2—peripheral nervous system neoplasm	2.1e-05	0.000129	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—HRAS—peripheral nervous system neoplasm	2.09e-05	0.000129	CbGpPWpGaD
Bepridil—CALM2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.000127	CbGpPWpGaD
Bepridil—CALM1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.000127	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.06e-05	0.000126	CbGpPWpGaD
Bepridil—CALM2—Immune System—HGF—peripheral nervous system neoplasm	2.06e-05	0.000126	CbGpPWpGaD
Bepridil—CALM1—Immune System—HGF—peripheral nervous system neoplasm	2.06e-05	0.000126	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—HRAS—peripheral nervous system neoplasm	2.05e-05	0.000126	CbGpPWpGaD
Bepridil—CALM1—Metabolism—TH—peripheral nervous system neoplasm	2.04e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Metabolism—TH—peripheral nervous system neoplasm	2.04e-05	0.000125	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	2.03e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	2.03e-05	0.000125	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.03e-05	0.000124	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.03e-05	0.000124	CbGpPWpGaD
Bepridil—CALM3—Signaling by WNT in cancer—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000124	CbGpPWpGaD
Bepridil—PDE1B—Disease—MYC—peripheral nervous system neoplasm	2.02e-05	0.000124	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	2.02e-05	0.000124	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	2.02e-05	0.000124	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2e-05	0.000123	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2e-05	0.000123	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	1.99e-05	0.000122	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—HRAS—peripheral nervous system neoplasm	1.99e-05	0.000122	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.98e-05	0.000122	CbGpPWpGaD
Bepridil—CALM1—Signaling by WNT in cancer—AKT1—peripheral nervous system neoplasm	1.96e-05	0.00012	CbGpPWpGaD
Bepridil—CALM2—Signaling by WNT in cancer—AKT1—peripheral nervous system neoplasm	1.96e-05	0.00012	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	1.95e-05	0.00012	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	1.95e-05	0.00012	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.93e-05	0.000118	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.9e-05	0.000117	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000116	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.88e-05	0.000116	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HRAS—peripheral nervous system neoplasm	1.88e-05	0.000115	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.86e-05	0.000115	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.86e-05	0.000115	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000114	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.83e-05	0.000112	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.82e-05	0.000112	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.81e-05	0.000111	CbGpPWpGaD
Bepridil—CALM3—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.81e-05	0.000111	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—NRAS—peripheral nervous system neoplasm	1.78e-05	0.000109	CbGpPWpGaD
Bepridil—CALM2—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000108	CbGpPWpGaD
Bepridil—CALM1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000108	CbGpPWpGaD
Bepridil—PDE1A—Disease—HRAS—peripheral nervous system neoplasm	1.74e-05	0.000107	CbGpPWpGaD
Bepridil—CALM3—Metabolism—GNAS—peripheral nervous system neoplasm	1.72e-05	0.000106	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HRAS—peripheral nervous system neoplasm	1.72e-05	0.000106	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—NRAS—peripheral nervous system neoplasm	1.72e-05	0.000106	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—NRAS—peripheral nervous system neoplasm	1.72e-05	0.000106	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.7e-05	0.000105	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.7e-05	0.000104	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.69e-05	0.000104	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000102	CbGpPWpGaD
Bepridil—CALM2—Metabolism—GNAS—peripheral nervous system neoplasm	1.67e-05	0.000102	CbGpPWpGaD
Bepridil—CALM1—Metabolism—GNAS—peripheral nervous system neoplasm	1.67e-05	0.000102	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000102	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.66e-05	0.000102	CbGpPWpGaD
Bepridil—PDE1A—Immune System—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000102	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.65e-05	0.000101	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.64e-05	0.000101	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.64e-05	0.000101	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.64e-05	0.000101	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.64e-05	0.000101	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.62e-05	9.98e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.61e-05	9.91e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—AKT1—peripheral nervous system neoplasm	1.61e-05	9.91e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.6e-05	9.85e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.6e-05	9.83e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.6e-05	9.83e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.6e-05	9.8e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.6e-05	9.8e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—HRAS—peripheral nervous system neoplasm	1.59e-05	9.75e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.57e-05	9.65e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PTPN11—peripheral nervous system neoplasm	1.55e-05	9.52e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.55e-05	9.51e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.55e-05	9.51e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.55e-05	9.5e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.54e-05	9.44e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—AKT1—peripheral nervous system neoplasm	1.53e-05	9.41e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.53e-05	9.4e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.52e-05	9.34e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.52e-05	9.34e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.52e-05	9.33e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—AKT1—peripheral nervous system neoplasm	1.52e-05	9.32e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.51e-05	9.26e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PTPN11—peripheral nervous system neoplasm	1.5e-05	9.21e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PTPN11—peripheral nervous system neoplasm	1.5e-05	9.21e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.49e-05	9.13e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.49e-05	9.13e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.44e-05	8.86e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTPN11—peripheral nervous system neoplasm	1.43e-05	8.79e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.42e-05	8.69e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—AKT1—peripheral nervous system neoplasm	1.4e-05	8.61e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.39e-05	8.57e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.39e-05	8.57e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTPN11—peripheral nervous system neoplasm	1.38e-05	8.5e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTPN11—peripheral nervous system neoplasm	1.38e-05	8.5e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—peripheral nervous system neoplasm	1.36e-05	8.35e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—peripheral nervous system neoplasm	1.32e-05	8.08e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—peripheral nervous system neoplasm	1.32e-05	8.08e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.31e-05	8.03e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—HRAS—peripheral nervous system neoplasm	1.3e-05	7.98e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.27e-05	7.81e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—HRAS—peripheral nervous system neoplasm	1.26e-05	7.72e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—HRAS—peripheral nervous system neoplasm	1.26e-05	7.72e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.23e-05	7.56e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—ERBB2—peripheral nervous system neoplasm	1.22e-05	7.52e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.22e-05	7.46e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.21e-05	7.42e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-05	7.38e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ERBB2—peripheral nervous system neoplasm	1.18e-05	7.28e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ERBB2—peripheral nervous system neoplasm	1.18e-05	7.28e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.17e-05	7.19e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.16e-05	7.14e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—AKT1—peripheral nervous system neoplasm	1.15e-05	7.05e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.13e-05	6.95e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HRAS—peripheral nervous system neoplasm	1.13e-05	6.95e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—ERBB2—peripheral nervous system neoplasm	1.13e-05	6.95e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.12e-05	6.9e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.11e-05	6.83e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—peripheral nervous system neoplasm	1.11e-05	6.82e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—AKT1—peripheral nervous system neoplasm	1.11e-05	6.82e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—ERBB2—peripheral nervous system neoplasm	1.09e-05	6.72e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—ERBB2—peripheral nervous system neoplasm	1.09e-05	6.72e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.09e-05	6.68e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	1.09e-05	6.68e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.07e-05	6.59e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—peripheral nervous system neoplasm	1.06e-05	6.49e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.03e-05	6.35e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.02e-05	6.26e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1e-05	6.15e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—peripheral nervous system neoplasm	1e-05	6.14e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—peripheral nervous system neoplasm	1e-05	6.14e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	9.93e-06	6.1e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.87e-06	6.06e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.87e-06	6.06e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.82e-06	6.03e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.69e-06	5.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.69e-06	5.95e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	9.6e-06	5.9e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	9.6e-06	5.9e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRAS—peripheral nervous system neoplasm	9.32e-06	5.72e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRAS—peripheral nervous system neoplasm	9.02e-06	5.54e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRAS—peripheral nervous system neoplasm	9.02e-06	5.54e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NRAS—peripheral nervous system neoplasm	8.6e-06	5.28e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NRAS—peripheral nervous system neoplasm	8.32e-06	5.11e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NRAS—peripheral nervous system neoplasm	8.32e-06	5.11e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—peripheral nervous system neoplasm	8.01e-06	4.92e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.92e-06	4.86e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—peripheral nervous system neoplasm	7.75e-06	4.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—peripheral nervous system neoplasm	7.75e-06	4.76e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.66e-06	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.66e-06	4.7e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.46e-06	4.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.22e-06	4.43e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.22e-06	4.43e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.19e-06	4.41e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.95e-06	4.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.95e-06	4.27e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—peripheral nervous system neoplasm	6.82e-06	4.19e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—peripheral nervous system neoplasm	6.6e-06	4.05e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—peripheral nervous system neoplasm	6.6e-06	4.05e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.59e-06	4.05e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.37e-06	3.91e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.37e-06	3.91e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—peripheral nervous system neoplasm	6.29e-06	3.87e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—peripheral nervous system neoplasm	6.09e-06	3.74e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—peripheral nervous system neoplasm	6.09e-06	3.74e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.03e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—peripheral nervous system neoplasm	6.02e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.83e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.83e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—peripheral nervous system neoplasm	5.82e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—peripheral nervous system neoplasm	5.82e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.61e-06	3.45e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—peripheral nervous system neoplasm	5.56e-06	3.41e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.43e-06	3.33e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.43e-06	3.33e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—peripheral nervous system neoplasm	5.38e-06	3.3e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—peripheral nervous system neoplasm	5.38e-06	3.3e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—peripheral nervous system neoplasm	4.65e-06	2.86e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.61e-06	2.83e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—peripheral nervous system neoplasm	4.5e-06	2.77e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—peripheral nervous system neoplasm	4.5e-06	2.77e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.46e-06	2.74e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.46e-06	2.74e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.41e-06	2.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.26e-06	2.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.26e-06	2.62e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.89e-06	2.39e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.77e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.77e-06	2.31e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.53e-06	2.17e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.32e-06	2.04e-05	CbGpPWpGaD
